HSANZ Free Communications 3: CLL / basic science lymphoid malignancy
Tracks
HSANZ
| Monday, October 19, 2026 |
| 8:30 AM - 10:00 AM |
| 502 |
Speaker
Prof Stephen Opat
Clinical Professor
Monash Health
Long-term follow-up for safety and efficacy of zanubrutinib in elderly (≥80 years) treatment-naïve CLL/SLL patients, including those with del(17p): subgroup analysis from the SEQUOIA trial
8:30 AM - 8:45 AMBiography
Clinical Professor Stephen Opat is an internationally renowned CLL and lymphoma expert. As Cancer Program Director at Monash Health, he leads over 80 clinical trials and founded the Australasian Lymphoma and Related Diseases Registry. A prolific researcher and global educator, he specializes in genomics, survivorship care, and innovative lymphoid treatments.
Prof Stephen Opat
Clinical Professor
Monash Health
First-line treatment of CLL/SLL with the all-oral combination of sonrotoclax (sonro) and zanubrutinib (zanu) achieves undetectable minimal residual disease (uMRD) rates of >90%, including in patients with del(17p)/TP53
8:45 AM - 9:00 AMBiography
Clinical Professor Stephen Opat is an internationally renowned CLL and lymphoma expert. As Cancer Program Director at Monash Health, he leads over 80 clinical trials and founded the Australasian Lymphoma and Related Diseases Registry. A prolific researcher and global educator, he specializes in genomics, survivorship care, and innovative lymphoid treatments.
Dr Joshua WD Tobin
Co-Group Lead
Mater Research
BCR neoantigens drive T-cell immunity and favourable outcomes in Chronic Lymphocytic Leukaemia
9:00 AM - 9:15 AMBiography
Dr Joshua Tobin is an emerging leader at Mater Research, advancing personalised immunotherapy for blood cancers. As Co-Group Leader with Professor Maher Gandhi, he focuses on lymphoma research, spanning immunology to clinical translation, aiming to understand immune–cancer interactions and develop innovative, patient-specific immunotherapy trials for Australians.
Dr Eric Wenlong Li
Phd Candidate
Walter and Eliza Hall Institute of Medical Research
MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF‑κB in mature B-cell malignancies
9:15 AM - 9:30 AMBiography
Dr Eric Wenlong Li is a clinical haematologist and haematopathologist with subspecialty interest in molecular diagnostics, and is near completing his PhD at the Walter and Eliza Hall Institute of Medical Research, concurrently a Molecular Haematopathology Fellow at the Peter MacCallum Cancer Centre.
Assoc Prof Collin Chin
Consultant Haematologist
Royal Perth Hospital
Pirtobrutinib in post-cBTKi chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): phase 1/2 BRUIN study with more than 5 years follow-Up (final update)
9:30 AM - 9:45 AMBiography
Associate Professor Collin Chin is a Clinician Researcher and Consultant Haematologist at Royal Perth Hospital. He completed fellowships at Peter MacCallum Cancer Centre and MD Anderson Cancer Center, and holds a Raine Foundation Clinician Research Fellowship. He focuses on B-cell non-Hodgkin lymphoma and immune effector cell therapies.
Prof Judith Trotman
Hematologist
Concord Repatriation General Hospital, University Of Sydney
BGB-16673, a Bruton tyrosine kinase degrader, in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the CaDAnCe-101 study
9:45 AM - 10:00 AMBiography
Judith Trotman (MBChB, FRACP, FRCPA) is Lymphoma and Community Partnerships Lead, Concord Repatriation General Hospital, University of Sydney; Chair of the ALLG Scientific Advisory Committee; Founder of Women in Lymphoma and develops digital initiatives in physician-patient partnerships, including the ClinTrial Refer App, and the WhiMSICAL and MyHodgkin MyHealth Apps.
Dr Anna Elinder Camburn
Haematologist
Health New Zealand Waitemata
Chairperson
Biography
Dr Hans Hahn
Haematologist
Royal Adelaide Hospital
Chairperson
Biography
Dr. Hans Uwe Hahn born 22.02.1961. Since March 2004 Consultant Haematologist CALHN/SA-Pathology.
Main interests: Haematopathology, malignant lymphoma and CLL, and transfusion medicine.
Site Clinical Director, SA-Pathology, The Queen Elizabeth Hospital, 2009-2018. Head of Clinical and Laboratory Haematology, The Queen Elizabeth Hospital, 2014-2018. Clinical Director Haematology, SA-Pathology, since 2017.
Graduated from the Medical School of the University of Heidelberg, Germany in 1989. MD in Immunology 1992 (Uni Heidelberg).
Fellow in Internal Medicine 1995 (Germany). Fellow in Haematology and Clinical Oncology 1998 (Germany).
Clinical Haematologist and Oncologist in Heidelberg and Hamburg (1998-2001).
Training in Laboratory Haematology in Adelaide 2002 –2003 and FRACP in 2003.
Passionate about his family, cycling and running, loves classical music and Italian cuisine.
